Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 18.6% | 16.9% | 20.9% | 22% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS | 3.55 | 0.33 | 0.39 | 0.35 |
| % Growth | 975.8% | -15.4% | 11.4% | – |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $0 | $0 | $0 |
| % Margin | 25.8% | 25% | 29% | 28.2% |